1 Min Read
March 7 (Reuters) - Veloxis Pharmaceuticals A/S:
* VELOXIS PHARMACEUTICALS - SUBMITTED SUPPLEMENTAL NEW DRUG APPLICATION TO U.S. FOOD & DRUG ADMINISTRATION SEEKING A NEW INDICATION FOR ENVARSUS XR Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.